Cargando…
Apelin/APJ system: A key therapeutic target for liver disease
Apelin, a new bioactive peptide, was identified as an endogenous ligand for APJ (Angiotensin II receptor-like 1). Apelin and its receptor have an abundant distribution in central nervous system and peripheral tissues, including liver. Apelin/APJ has diverse physiological and pathological effects, in...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762386/ https://www.ncbi.nlm.nih.gov/pubmed/29340118 http://dx.doi.org/10.18632/oncotarget.22841 |
_version_ | 1783291677891362816 |
---|---|
author | Lv, Shuang-Yu Cui, Binbin Chen, Wei-Dong Wang, Yan-Dong |
author_facet | Lv, Shuang-Yu Cui, Binbin Chen, Wei-Dong Wang, Yan-Dong |
author_sort | Lv, Shuang-Yu |
collection | PubMed |
description | Apelin, a new bioactive peptide, was identified as an endogenous ligand for APJ (Angiotensin II receptor-like 1). Apelin and its receptor have an abundant distribution in central nervous system and peripheral tissues, including liver. Apelin/APJ has diverse physiological and pathological effects, including regulation of cardiovascular function, angiogenesis, fluid homeostasis and so on. Apelin/APJ system may act as a novel potential therapeutic target for liver disease. In this article, we review the role of apelin/APJ system in liver fibrosis, hepatitis, hepatic cirrhosis, liver injury and metabolic liver disease. |
format | Online Article Text |
id | pubmed-5762386 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-57623862018-01-16 Apelin/APJ system: A key therapeutic target for liver disease Lv, Shuang-Yu Cui, Binbin Chen, Wei-Dong Wang, Yan-Dong Oncotarget Review Apelin, a new bioactive peptide, was identified as an endogenous ligand for APJ (Angiotensin II receptor-like 1). Apelin and its receptor have an abundant distribution in central nervous system and peripheral tissues, including liver. Apelin/APJ has diverse physiological and pathological effects, including regulation of cardiovascular function, angiogenesis, fluid homeostasis and so on. Apelin/APJ system may act as a novel potential therapeutic target for liver disease. In this article, we review the role of apelin/APJ system in liver fibrosis, hepatitis, hepatic cirrhosis, liver injury and metabolic liver disease. Impact Journals LLC 2017-12-01 /pmc/articles/PMC5762386/ /pubmed/29340118 http://dx.doi.org/10.18632/oncotarget.22841 Text en Copyright: © 2017 Lv et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Review Lv, Shuang-Yu Cui, Binbin Chen, Wei-Dong Wang, Yan-Dong Apelin/APJ system: A key therapeutic target for liver disease |
title | Apelin/APJ system: A key therapeutic target for liver disease |
title_full | Apelin/APJ system: A key therapeutic target for liver disease |
title_fullStr | Apelin/APJ system: A key therapeutic target for liver disease |
title_full_unstemmed | Apelin/APJ system: A key therapeutic target for liver disease |
title_short | Apelin/APJ system: A key therapeutic target for liver disease |
title_sort | apelin/apj system: a key therapeutic target for liver disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762386/ https://www.ncbi.nlm.nih.gov/pubmed/29340118 http://dx.doi.org/10.18632/oncotarget.22841 |
work_keys_str_mv | AT lvshuangyu apelinapjsystemakeytherapeutictargetforliverdisease AT cuibinbin apelinapjsystemakeytherapeutictargetforliverdisease AT chenweidong apelinapjsystemakeytherapeutictargetforliverdisease AT wangyandong apelinapjsystemakeytherapeutictargetforliverdisease |